<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39576127</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1612-1880</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Nov</Month><Day>22</Day></PubDate></JournalIssue><Title>Chemistry &amp; biodiversity</Title><ISOAbbreviation>Chem Biodivers</ISOAbbreviation></Journal><ArticleTitle>Uncovering the Therapeutic Potential of Propolis Extract in Managing Hyperinflammation and Long COVID-19: A Comprehensive Bioinformatics Study.</ArticleTitle><Pagination><StartPage>e202401947</StartPage><MedlinePgn>e202401947</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/cbdv.202401947</ELocationID><Abstract><AbstractText>Hyperinflammation is significant factor in long COVID, impacting over 65 million post-COVID-19 individuals globally. Herbal remedies, including propolis, show promise in reducing severity and pro-inflammatory cytokines. However, the natural pharmacological role of propolis in COVID-19 management remains underexplored. Employing network pharmacology and in silico techniques, we assessed propolis extract's potential in countering SARS-CoV-2-induced inflammation. We identified 80 flavonoids via LC-MS/MS QTOF and employed 11 anti-inflammatory drugs as references for inflammation target fishing. Utilizing in silico techniques encompassing target fishing, molecular docking, and dynamics, we examined propolis' effects. We identified 1105 gene targets connected to inflammation through multiple validated target predictors. By integrating SARS-CoV-2 DEGs from GSE147507 with these targets, we Identify precisely 25 inflammation-COVID-19-associated propolis targets, including STAT1, NOS2, CFB, EIF2K2, NPY5R, and BTK. Enrichment analyses highlighted primary pharmacological pathways related to Epstein-Barr virus infection and COVID-19. Molecular docking validated Isokaempferide, Iristectorigenin B, 3'-Methoxypuerarin, Cosmosin, and Baicalein-7-O-&#x3b2;-D glucopyranoside, which exhibited strong binding affinity and stability with relevant genes. Moreover, our findings indicate that propolis ligands could potentially suppress reactivation of Epstein-Barr Virus infections in post-COVID-19 cases. These findings highlight propolis as potential supplement to alleviate inflammation in COVID-19 patients and those with prolonged symptoms, requiring additional clinical validation for confirmation.</AbstractText><CopyrightInformation>&#xa9; 2024 Wiley&#x2010;VCH GmbH.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Anshori</LastName><ForeName>Isa</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institut Teknologi Bandung, School of Electrical Engineering and Informatics, Jl. Ganesa No. 10, 40132, Bandung, INDONESIA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marcius</LastName><ForeName>Donny</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institut Teknologi Bandung, School of Electrical Engineering and Informatics, Jalan Ganeca 10, Bandung, 40132, Bandung, INDONESIA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Syaifie</LastName><ForeName>Putri Hawa</ForeName><Initials>PH</Initials><AffiliationInfo><Affiliation>Nano Center Indonesia, Nano Center Indonesia, Jalan PUSPIPTEK, 15314, South Tangerang, INDONESIA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siregar</LastName><ForeName>Khalish Arsy Al Khairy</ForeName><Initials>KAAK</Initials><AffiliationInfo><Affiliation>Universitas Muhammadiyah Kalimantan Timur, Faculty of Pharmacy, Jl. Ir. H. Juanda No.15, 75124, Samarinda, INDONESIA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Syakuran</LastName><ForeName>Luqman Abdan</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Nano Center Indonesia, Nano Center Indonesia, Jalan PUSPIPTEK, South Tangerang, 15314, South Tangerang, INDONESIA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jauhar</LastName><ForeName>Muhammad Miftah</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Nano Center Indonesia, Nano Center Indonesia, Jalan PUSPIPTEK, South Tangerang, 15314, South Tangerang, INDONESIA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arda</LastName><ForeName>Adzani Gaisani</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Nano Center Indonesia, Nano Center Indonesia, Jalan PUSPIPTEK, South Tangerang, 15314, South Tangerang, INDONESIA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shalannanda</LastName><ForeName>Wervyan</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Institut Teknologi Bandung, School of Electrical Engineering and Informatics, Jalan Ganeca 10, 40132, Bandung, INDONESIA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mardliyati</LastName><ForeName>Etik</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>National Research and Innovation Agency Republic of Indonesia, Research Center for Vaccine and Drug, Jalan Raya Bogor, 16911, Cibinong, INDONESIA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Chem Biodivers</MedlineTA><NlmUniqueID>101197449</NlmUniqueID><ISSNLinking>1612-1872</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">LC-MS/MS</Keyword><Keyword MajorTopicYN="N">Molecular docking</Keyword><Keyword MajorTopicYN="N">Network pharmacology</Keyword><Keyword MajorTopicYN="N">molecular dynamic</Keyword><Keyword MajorTopicYN="N">propolis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>11</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>22</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>22</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>22</Day><Hour>9</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39576127</ArticleId><ArticleId IdType="doi">10.1002/cbdv.202401947</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>